Form 4 holding
Director
Lexaria Bioscience Corp.
- Security class
- common shares
- Shares / value
- 3,100
- Estimated value
- $9,703
- Report date
- 12 Aug 2024
- Price
- $3.13
- Ownership
- Direct
Catherine C. Turkel - Director at Lexaria Bioscience Corp.
Issuer-level insider activity
- Role
- Director
- Issuer symbol
- LEXX on Nasdaq
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
No buys or sells have been reported by Catherine C. Turkel since 02 Jun 2025
Reported holdings for Catherine C. Turkel in Lexaria Bioscience Corp.
Form 4 holding
Director
Lexaria Bioscience Corp.
- Security class
- Stock Options
- Shares / value
- 27,000
- Estimated value
- Report date
- 12 Aug 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 12,000
Form 4 holding
Director
Lexaria Bioscience Corp.
- Security class
- Stock Options
- Shares / value
- 15,000
- Estimated value
- Report date
- 26 Apr 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 1,600
Transaction history for Catherine C. Turkel in Lexaria Bioscience Corp.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.